Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Immune System Profiling Following Autologous Stem Cell Transplant for High-Risk Neuroblastoma Predicts Disease-Free Survival

Michele L Nassin, MD, Elitsa V Nicolaou, MD, Hillary M Hecktman, CPNP-AC, Caitlin W Cohen, CPNP-AC, Susan L Cohn, MD, John M Cunningham, MD, James L LaBelle, MD PhD

Blood (2016) 128 (22): 2251.

https://doi.org/10.1182/blood.V128.22.2251.2251

Published: 2016

Journal Articles

Defibrotide for Prophylaxis of Hepatic Veno-Occlusive Disease in Autologous, Non-Purged Peripheral Stem Cell Transplantation for High Risk Neuroblastoma Patients

Emel Unal, MD PROF, Nurdan Tacyildiz, MDPROF, Gulsan Yavuz, PROF, MD, Handan Dincaslan, MD, Gulsah Tanyildiz, MD, Erol Ayyildiz, Muhit Ozcan, MD

Blood (2014) 124 (21): 5910.

https://doi.org/10.1182/blood.V124.21.5910.5910

Published: 2014

Journal Articles

High-Dose Chemotherapy and Autologous Stem Cell Transplantation In Patients With High-Risk Neuroblastoma : Results Of Turkish Pediatric Oncology Group- Neuroblastoma 2003 (TPOG-NBL 2003) Protocol

Serap Aksoylar, MD, Ali Varan, MD, Canan Vergin, Volkan Hazar, MD, Ferhan Akici, MD, Ayhan Dagdeviren, MD, Emel Unal, MD, Haldun Oniz, MD, Sema Anak, MD, Vedat Koseoglu, MD, Dilek Ince, MD, Nur Olgun

Blood (2013) 122 (21): 3411.

https://doi.org/10.1182/blood.V122.21.3411.3411

Published: 2013

Journal Articles

High Content Screening Identifies Synthetic Lethality Of Retinoid Receptor Agonists In IKZF1 -Mutated BCR-ABL1 positive Acute Lymphoblastic Leukemia

Michelle Churchman, Ph.D., Jonathan Low, Ph.D., Debbie Payne-Turner, Shann-Ching Chen, PhD, Jing Ma, PhD, Mark J. Althoff, Faiyaz Notta, PhD, John E. Dick, PhD, Laura Janke, DVM, PhD, Rodney Kiplin Guy, Ph.D, Taosheng Chen, Ph.D., Charles G. Mullighan, MBBS, MSc, MD, FRACP, FRCPA

Blood (2013) 122 (21): 172.

https://doi.org/10.1182/blood.V122.21.172.172

Published: 2013

Journal Articles

Pilot Study: Favorable Outcomes with Addition of Topotecan to Busulfan/Melphalan As High-Dose Myeloablative Therapy Followed by Autologous Hematopoietic Cell Transplantation

Joseph Rosenthal, MD, Anna Pawlowska, MD, Jerry Cheng, MD, Steven Kechichian, Debbie Hitt, Mary Suarez, Ni-Chun Tsai, MS MPH, Joycelynne Palmer, PHD

Blood (2012) 120 (21): 4553.

https://doi.org/10.1182/blood.V120.21.4553.4553

Published: 2012

Journal Articles

Maintenance Low Dose 13 Cis-Retinoic Acid and Alpha Tocopherol Improves Survival Compared to High Dose Therapy for 6 Months In LOW and INT-1/2 Stage MDS: Role for Prevention Trial

Emmanuel C. Besa, Professor of Medical Oncology, Joseph Vadakara, Fellow, Physician

Blood (2011) 118 (21): 5053.

https://doi.org/10.1182/blood.V118.21.5053.5053

Published: 2011

Journal Articles

High Throughput Screening Reveals Unique Sensitivity of CD34+CD38- AML Cells to Isotretinoin and Tretinoin

Wen Xie, MS, Duane C Hassane, PhD, Craig T. Jordan, PhD, Gail J. Roboz, MD, Monica L. Guzman, PhD

Blood (2011) 118 (21): 1430.

https://doi.org/10.1182/blood.V118.21.1430.1430

Published: 2011

Journal Articles

Long Term Follow-up of a Population of Low-Intermediate Risk Myelodisplastyc Syndrome Patients Treated with a Combination of Recombinant Erythropoietin, 13-Cis-Retinoic Acid and Dihydroxylated Vitamin D3 Confirms the Positive Role of Erythroid Response on Survival

Dario Ferrero, Elena Crisà, Antonella Darbesio, Cristina Foli, Valentina Giai, Mario Boccadoro

Blood (2010) 116 (21): 4968.

https://doi.org/10.1182/blood.V116.21.4968.4968

Published: 2010

Journal Articles

Long-Term Complete Responses to Combination Therapies in Sézary Patients.

Seema Daulat, MD, Rakhshandra Talpur, Chitra Hosing, Madeleine Duvic, MD

Blood (2009) 114 (22): 3369.

https://doi.org/10.1182/blood.V114.22.3369.3369

Published: 2009

Journal Articles

HLA-Identical Umbilical Cord Blood Transplantation from a Sibling Donor in Juvenile myelomonocytic Leukemia

Andrica de Vries, MD, Robbert Bredius, MD, PhD, Arjan Lankester, MD, PhD, Marc Bierings, MD, PhD, Monika Trebo, MD, PhD, Jan Stary, MD, PhD, Marco Zecca, MD, PhD, Franco Locatelli, MD, PhD, Charlotte Niemeyer, MD, PhD, Marry Van Den Heuvel, MD, PhD

Blood (2008) 112 (11): 4428.

https://doi.org/10.1182/blood.V112.11.4428.4428

Published: 2008

Journal Articles

A Maintenance Therapy with Differentiating Agents and Low-Dose Chemotherapy Increases Remission Duration and Survival in High Risk AML and MDS Patients.

Dario Ferrero, MD, Chiara Dellacasa, MD, Margherita Bonferroni, MD, Mariella Grasso, MD, Elisabetta Campa, MD, Valentina Giai, MD, Mariella Genuardi, Mario Boccadoro, MD

Blood (2005) 106 (11): 4614.

https://doi.org/10.1182/blood.V106.11.4614.4614

Published: 2005

Journal Articles

Phase II Window Study of the Farnesyltransferase Inhibitor R115777 (Zarnestra®) in Untreated Juvenile Myelomonocytic Leukemia (JMML): A Children’s Oncology Group Study.

Robert P. Castleberry, MD, Mignon L. Loh, MD, Nalini Jayaprakash, April Peterson, Vicky Casey, Myron Chang, PhD, Brigitte Widemann, MD, Peter D. Emanuel, MD

Blood (2005) 106 (11): 2587.

https://doi.org/10.1182/blood.V106.11.2587.2587

Published: 2005

Journal Articles

Rapid Cyclosporine Tapering and Isotretinoin Usage after Unrelated Donor Hematopoietic Stem Cell Transplantation in Juvenile Myelomonocytic Leukemia.

Keon Hee Yoo, MD, Soo Hyun Lee, MD, Ki Woong Sung, MD, Hong Hoe Koo, MD, Hye Lim Jung, MD

Blood (2004) 104 (11): 5188.

https://doi.org/10.1182/blood.V104.11.5188.5188

Published: 2004

Journal Articles

Efficacy of Recombinant Erythropoietin + 13-cis Retinoic Acid + Dihydroxylated Vitamin D3 in the Treatment of Anemia of Low-Intermediate Risk Myelodysplastic Syndrome Patients.

Dario Ferrero, MD, Chiara Dellacasa, MD, Antonella Darbesio, MD, Marilena Bertini, MD, Patrizia Pregno, MD, Mario Boccadoro, MD

Blood (2004) 104 (11): 4732.

https://doi.org/10.1182/blood.V104.11.4732.4732

Published: 2004

Journal Articles

Bone Marrow Replacement with a Clone Harboring Novel t(4;11)(p12;q23) Involving MLL during Neuroblastoma Treatment Is Not Associated with Leukemia.

Blaine W. Robinson, PhD, Andrew Lee, Nai-Kong V. Cheung, MD, PhD, Carolyn A. Felix, MD

Blood (2004) 104 (11): 2903.

https://doi.org/10.1182/blood.V104.11.2903.2903

Published: 2004

NARROW

Immune System Profiling Following Autologous Stem Cell Transplant for High-Risk Neuroblastoma Predicts Disease-Free Survival

Defibrotide for Prophylaxis of Hepatic Veno-Occlusive Disease in Autologous, Non-Purged Peripheral Stem Cell Transplantation for High Risk Neuroblastoma Patients

High-Dose Chemotherapy and Autologous Stem Cell Transplantation In Patients With High-Risk Neuroblastoma : Results Of Turkish Pediatric Oncology Group- Neuroblastoma 2003 (TPOG-NBL 2003) Protocol

High Content Screening Identifies Synthetic Lethality Of Retinoid Receptor Agonists In IKZF1 -Mutated BCR-ABL1 positive Acute Lymphoblastic Leukemia

Pilot Study: Favorable Outcomes with Addition of Topotecan to Busulfan/Melphalan As High-Dose Myeloablative Therapy Followed by Autologous Hematopoietic Cell Transplantation

Maintenance Low Dose 13 Cis-Retinoic Acid and Alpha Tocopherol Improves Survival Compared to High Dose Therapy for 6 Months In LOW and INT-1/2 Stage MDS: Role for Prevention Trial

High Throughput Screening Reveals Unique Sensitivity of CD34+CD38- AML Cells to Isotretinoin and Tretinoin

Long Term Follow-up of a Population of Low-Intermediate Risk Myelodisplastyc Syndrome Patients Treated with a Combination of Recombinant Erythropoietin, 13-Cis-Retinoic Acid and Dihydroxylated Vitamin D3 Confirms the Positive Role of Erythroid Response on Survival

Long-Term Complete Responses to Combination Therapies in Sézary Patients.

HLA-Identical Umbilical Cord Blood Transplantation from a Sibling Donor in Juvenile myelomonocytic Leukemia

A Maintenance Therapy with Differentiating Agents and Low-Dose Chemotherapy Increases Remission Duration and Survival in High Risk AML and MDS Patients.

Phase II Window Study of the Farnesyltransferase Inhibitor R115777 (Zarnestra®) in Untreated Juvenile Myelomonocytic Leukemia (JMML): A Children’s Oncology Group Study.

Rapid Cyclosporine Tapering and Isotretinoin Usage after Unrelated Donor Hematopoietic Stem Cell Transplantation in Juvenile Myelomonocytic Leukemia.

Efficacy of Recombinant Erythropoietin + 13-cis Retinoic Acid + Dihydroxylated Vitamin D3 in the Treatment of Anemia of Low-Intermediate Risk Myelodysplastic Syndrome Patients.

Bone Marrow Replacement with a Clone Harboring Novel t(4;11)(p12;q23) Involving MLL during Neuroblastoma Treatment Is Not Associated with Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only